Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tagrisso
Pharma
AstraZeneca dual lung cancer wins softened by bispecific fail
The successes of Enhertu and Orpathys-Tagrisso in lung cancer niches were overshadowed by the phase 3 crash of volrustomig in first-line NSCLC.
Angus Liu
Aug 17, 2026 10:56am
AZ leans on cancer, rare disease muscle in solid Q2
Jul 27, 2026 10:21am
AZ's $80B revenue target 'very much within reach,' CFO says
Jan 14, 2026 10:00am
FDA approves J&J's new challenge to Tagrisso
Dec 18, 2025 10:40am
AstraZeneca bolsters Tagrisso's case amid J&J rivalry
Sep 7, 2025 2:15am
AstraZeneca debuts TV ad for Tagrisso lung cancer treatment
Jul 23, 2025 1:37pm
